# Citing PanDrugs

When citing our application, please refer to **PanDrugs publication:**

> [Piñeiro-Yáñez, E., Reboiro-Jato, M., Gómez-López, G., Perales-Patón, J., Troulé, K., Rodríguez, J. M., Tejero, H., Shimamura, T., López-Casas, P. P., Carretero, J., Valencia, A., Hidalgo, M., Glez-Peña, D., & Al-Shahrour, F. (2018). PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. Genome medicine, 10 (1), 41.](https://doi.org/10.1186/s13073-018-0546-1)

## Related work

You may also find interesting these PanDrugs-related publications:

1. [Goldman, M. J., Zhang, J., Fonseca, N. A., Cortés-Ciriano, I., Xiang, Q., Craft, B., Piñeiro-Yáñez, E., O'Connor, B. D., Bazant, W., Barrera, E., Muñoz-Pomer, A., Petryszak, R., Füllgrabe, A., Al-Shahrour, F., Keays, M., Haussler, D., Weinstein, J. N., Huber, W., Valencia, A., Park, P. J., … Vazquez, M. (2020). A user guide for the online exploration and visualization of PCAWG data. *Nature communications, 11*(1), 3400.](https://doi.org/10.1038/s41467-020-16785-6)

2. [Fernández-Navarro, P., López-Nieva, P., Piñeiro-Yañez, E., Carreño-Tarragona, G., Martinez-López, J., Sánchez Pérez, R., Aroca, Á., Al-Shahrour, F., Cobos-Fernández, M. Á., & Fernández-Piqueras, J. (2019). The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data. *BMC cancer, 19*(1), 1005.](https://doi.org/10.1186/s12885-019-6209-9)

3. [Piñeiro-Yáñez, E., Jiménez-Santos, M. J., Gómez-López, G., & Al-Shahrour, F. (2019). In Silico Drug Prescription for Targeting Cancer Patient Heterogeneity and Prediction of Clinical Outcome. *Cancers, 11*(9), 1361.](https://doi.org/10.3390/cancers11091361)
